BioNTech SE ADR (NASDAQ: BNTX) is 7.75% higher on its value in year-to-date trading and has touched a low of $76.53 and a high of $131.49 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BNTX stock was last observed hovering at around $111.89 in the last trading session, with the day’s gains setting it 10.89%.
Currently trading at $122.78, the stock is 3.67% and 4.63% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.21 million and changing 9.73% at the moment leaves the stock 19.16% off its SMA200. BNTX registered 30.81% gain for a year compared to 6-month gain of 48.21%. The firm has a 50-day simple moving average (SMA 50) of $117.257 and a 200-day simple moving average (SMA200) of $102.86185.
The stock witnessed a 9.21% loss in the last 1 month and extending the period to 3 months gives it a 12.92%, and is 2.37% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.88% over the week and 4.30% over the month.
BioNTech SE ADR (BNTX) has around 3082 employees, a market worth around $29.44B and $3.30B in sales. Profit margin for the company is -15.20%. Distance from 52-week low is 60.43% and -6.62% from its 52-week high. The company has generated returns on investments over the last 12 months (-2.33%).
with sales reaching $1.16B over the same period.The EPS is expected to shrink by -183.25% this year, but quarterly earnings will post -30.70% year-over-year. Quarterly sales are estimated to shrink -21.66% in year-over-year returns.
The shares outstanding are 239.74M, and float is at 239.44M with Short Float at 1.15%.
The top institutional shareholder in the company is BAILLIE GIFFORD & CO with over 8.28 million shares valued at $665.08 million. The investor’s holdings represent 3.4408 of the BNTX Shares outstanding. As of 2024-06-30, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 4.79 million shares valued at $384.89 million to account for 1.9922 of the shares outstanding. The other top investors are FLOSSBACH VON STORCH AG which holds 4.38 million shares representing 1.8207 and valued at over $351.94 million, while HARDING LOEVNER LP holds 1.2168 of the shares totaling 2.93 million with a market value of $235.22 million.
BioNTech SE ADR (BNTX) Insider Activity
Still, SEC filings show that on Dec 09 ’24, ATHOS KG (10% Owner) Proposed Sale 53,716 shares at an average price of $121.72 for $6.54 million. The insider now directly holds shares of BioNTech SE ADR (BNTX).
